YungShin Global Holding Corp

YungShin Global Holding Corp maintains a strong capital structure with a debt-to-equity ratio of 0.14, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 3.47, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's free cash flow is negative at -129.82 million TWD, which may signal pressure on its ability to fund operations without external financing. In terms of profitability, YungShin Global Holding Corp reports a return on equity (ROE) of 10.8% and a return on assets (ROA) of 6.98%, both of which are above the industry median for pharmaceutical companies. These metrics suggest the company is effectively utilizing its equity and asset base to generate returns. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This concentration may expose the company to higher operational and market risks if demand in its primary market fluctuates. Looking ahead, the company's revenue is projected to grow in the current fiscal year, with a positive outlook for the next fiscal year. The capital expenditure of -508.41 million TWD indicates a reduction in investment in physical assets, which may reflect a strategic shift or a focus on cost optimization. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints, although the company's strong equity position and low debt levels mitigate this risk. No significant dilution events have been reported, and the company's shares outstanding remain unchanged between basic and diluted shares. Recent filings and transcripts do not indicate any material events that would significantly alter the company's strategic direction or financial performance. The company's ESG profile is strong, with a governance score of 72.29 and a social score of 54.96, although its ESG controversies score is at the maximum of 100, indicating no reported controversies.